In: Nursing
1. Discuss the limitations of haematology reference ranges.
2. Discuss automated haematology analysers (Beckman Coulter haematology analyser) in detail.
2. Discuss automated haematology analysers (Beckman Coulter haematology analyser) in detail.
Hematology analyzers are used widely in patient and research settings to count and characterize blood cells for disease detection and monitoring. Basic analyzers return a complete blood count (CBC) with a three-part differential white blood cell (WBC) count. Sophisticated analyzers measure cell morphology and can detect small cell populations to diagnose rare blood conditions.
Hematology analyzer technology
The three main physical technologies used in hematology analyzers are: electrical impedance, flow cytometry, and fluorescent flow cytometry. These are used in combination with chemical reagents that lyse or alter blood cells to extend the measurable parameters. For example, electrical impedance can differentiate red blood cells (RBCs), WBCs, and platelets by volume. Adding a nucleating agent that shrinks lymphocytes more than other WBCs makes it possible to differentiate lymphocytes by volume.
Electrical impedance
The traditional method for counting cells is electrical impedance, also known as the Coulter Principle. It is used in almost every hematology analyzer.
Whole blood is passed between two electrodes through an aperture so narrow that only one cell can pass through at a time. The impedance changes as a cell passes through. The change in impedance is proportional to cell volume, resulting in a cell count and measure of volume.
Impedance analysis returns CBCs and three-part WBC differentials (granulocytes, lymphocytes, and monocytes) but cannot distinguish between the similarly sized granular leukocytes: eosinophils, basophils, and neutrophils.
Counting rates of up to 10,000 cells per second can be achieved and a typical impedance analysis can be carried out in less than a minute.
Flow cytometry
Laser flow cytometry is more expensive than impedance analysis, due to the requirement for expensive reagents, but returns detailed information about the morphology of blood cells. It is an excellent method for determining five-part WBC differentials.
A single-cell stream passes through a laser beam. The absorbance is measured, and the scattered light is measured at multiple angles to determine the cell’s granularity, diameter, and inner complexity. These are the same cell morphology characteristics that can be determined manually from a slide.
Fluorescent flow cytometry
Adding fluorescent reagents extends the use of flow cytometry to measure specific cell populations. Fluorescent dyes reveal the nucleus-plasma ratio of each stained cell. It is useful for the analysis of platelets, nucleated RBCs, and reticulocytes.
1. Discuss the limitations of haematology reference ranges.
Reference ranges for blood tests are sets of values used by a health professional to interpret a set of medical test results from blood samples.Reference ranges for blood tests are studied within the field of clinical chemistry (also known as "clinical biochemistry", "chemical pathology" or "pure blood chemistry"), the area of pathology that is generally concerned with analysis of bodily fluids.
Ions and trace metals
Test | Lower limit | Upper limit | Unit* | Comments |
---|---|---|---|---|
Sodium (Na) | 135,[9] 137[4][10] | 145,[4][10] 147[9] | mmol/L or mEq/L[9] | See hyponatremia or hypernatremia |
310,[11] 320[11] | 330,[11] 340[11] | mg/dL | ||
Potassium (K) | 3.5,[4][9] 3.6[10] | 5.0,[4][9][10] 5.1 | mmol/L or mEq/L[9] | See hypokalemia or hyperkalemia |
14[12] | 20[12] | mg/dL | ||
Chloride (Cl) | 95,[9] 98,[13] 100[4] | 105,[9] 106,[13] 110[4] | mmol/L or mEq/L[9] | See hypochloremia or hyperchloremia |
340[14] | 370[14] | mg/dL | ||
Ionized calcium (Ca) | 1.03,[15] 1.10[4] | 1.23,[15] 1.30[4] | mmol/L | See hypocalcaemia or hypercalcaemia |
4.1,[16] 4.4[16] | 4.9,[16] 5.2[16] | mg/dL | ||
Total calcium (Ca) | 2.1,[9][17] 2.2[4] | 2.5,[4][17] 2.6,[17] 2.8[9] | mmol/L | |
8.4,[9] 8.5[18] | 10.2,[9] 10.5[18] | mg/dL | ||
Total serum iron (TSI) – male | 65,[19] 76[10] | 176,[19] 198[10] | µg/dL | See hypoferremia or the following: iron overload (hemochromatosis), iron poisoning, siderosis, hemosiderosis, hyperferremia |
11.6,[20][21] 13.6[21] | 30,[20] 32,[21] 35[21] | μmol/L | ||
Total serum iron (TSI) – female | 26,[10] 50[19] | 170[10][19] | µg/dL | |
4.6,[21] 8.9[20] | 30.4[20] | μmol/L | ||
Total serum iron (TSI) – newborns | 100[19] | 250[19] | µg/dL | |
18[21] | 45[21] | µmol/L | ||
Total serum iron (TSI) – children | 50[19] | 120[19] | µg/dL | |
9[21] | 21[21] | µmol/L | ||
Total iron-binding capacity (TIBC) | 240,[19] 262[10] | 450,[19] 474[10] | μg/dL | |
43,[21] 47[21] | 81,[21] 85[21] | µmol/L | ||
Transferrin | 190,[22] 194,[4] 204[10] | 326,[4] 330,[22] 360[10] | mg/dL | |
25[23] | 45[23] | μmol/L | ||
Transferrin saturation | 20[19] | 50[19] | % | |
Ferritin – Males and postmenopausal females | 12[24] | 300[24][25] | ng/mL or µg/L | |
27[26] | 670[26] | pmol/L | ||
Ferritin – premenopausal females | 12[24] | 150[24] – 200[25] | ng/mL or µg/L | |
27[26] | 330[26] – 440[26] | pmol/L | ||
Ammonia | 10,[27] 20[28] | 35,[27] 65[28] | μmol/L | See hypoammonemia and hyperammonemia |
17,[29] 34[29] | 60,[29] 110[29] | μg/dL | ||
Copper (Cu) | 70[18] | 150[18] | µg/dL | See hypocupremia or hypercupremia |
11[30][31] | 24[30] | μmol/L | ||
Ceruloplasmin | 15[18] | 60[18] | mg/dL | |
1[32] | 4[32] | μmol/L | ||
Phosphate (HPO42−) | 0.8 | 1.5[33] | mmol/L | See hypophosphatemia or hyperphosphatemia |
Inorganic phosphorus (serum) | 1.0[9] | 1.5[9] | mmol/L | |
3.0[9] | 4.5[9] | mg/dL | ||
Zinc (Zn) | 60,[34] 72[35] | 110,[35] 130[34] | μg/dL | See zinc deficiency or zinc poisoning |
9.2,[36] 11[4] | 17,[4] 20[36] | µmol/L | ||
Magnesium | 1.5,[18] 1.7[37] | 2.0,[18] 2.3[37] | mEq/L or mg/dL | See hypomagnesemia or hypermagnesemia |
0.6,[38] 0.7[4] | 0.82,[38] 0.95[4] | mmo |
Test |
Arterial/Venous | Lower limit | Upper limit | Unit |
---|---|---|---|---|
pH | Arterial | 7.34,[10] 7.35[9] | 7.44,[10] 7.45[9] | |
Venous | 7.31[40] | 7.41[40] | ||
[H+] | Arterial | 36[9] | 44[9] | nmol/L |
3.6[41] | 4.4[41] | ng/dL | ||
Base excess | Arterial & venous[40] | −3[40] | +3[40] | mEq/L |
Oxygen partial pressure (pO2) | Arterial pO2 | 10,[9] 11[42] | 13,[42] 14[9] | kPa |
75,[9][10] 83[18] | 100,[10] 105[9] | mmHg or torr | ||
Venous | 4.0[42] | 5.3[42] | kPa | |
30[40] | 40[40] | mmHg or torr | ||
Oxygen saturation | Arterial | 94,[40] 95,[13] 96[18] | 100[13][18] | % |
Venous | Approximately 75[13] | |||
Carbon dioxide partial pressure (pCO2) | Arterial PaCO2 | 4.4,[9] 4.7[42] | 5.9,[9] 6.0[42] | kPa |
33,[9] 35[10] | 44,[9] 45[10] | mmHg or torr | ||
Venous | 5.5,[42] | 6.8[42] | kPa | |
41[40] | 51[40] | mmHg or torr | ||
Absolute content of carbon dioxide (CO2) | Arterial | 23[40] | 30[40] | mmol/L |
100[43] | 132[43] | mg/dL | ||
Bicarbonate (HCO3−) | Arterial & venous | 18[18] | 23[18] | mmol/L |
110[44] | 140[44] | mg/dL | ||
Standard bicarbonate (SBCe) | Arterial & venous | 21, 22[9] | 27, 28[9] | mmol/L or mEq/L[9] |
134[44] | 170[44] | mg/dL |
Liver function
Liver function tests
Test | Patient type | Lower limit | Upper limit | Unit | Comments |
---|---|---|---|---|---|
Total protein (TotPro) | 60,[9] 63[10] | 78,[9] 82,[10] 84[18] | g/L | See serum total protein Interpretation | |
Albumin | 35[9][45] | 48,[10] 55[9] | g/L | See hypoalbuminemia | |
3.5[10] | 4.8,[10] 5.5[9] | U/L | |||
540[46] | 740[46] | μmol/L | |||
Globulins | 23[9] | 35[9] | g/L | ||
Total bilirubin | 1.7,[47] 2,[9] 3.4,[47] 5[4] | 17,[9][47] 22,[47] 25[4] | μmol/L | ||
0.1,[9] 0.2,[10] 0.29[48] | 1.0,[9][18] 1.3,[10] 1.4[48] | mg/dL | |||
Direct/conjugated bilirubin | 0.0[9] or N/A[4] | 5,[9] 7[4][47] | μmol/L | ||
0[9][10] | 0.3,[9][10] 0.4[18] | mg/dL | |||
Alanine transaminase (ALT/ALAT[4]) | 5,[49] 7,[10] 8[9] | 20,[9] 21,[13] 56[10] | U/L | Also called serum glutamic pyruvic transaminase (SGPT) | |
Female | 0.15[4] | 0.75[4] | µkat/L | ||
Male | 0.15[4] | 1.1[4] | |||
Aspartate transaminase (AST/ASAT[4]) | Female | 6[50] | 34[50] | IU/L | Also called serum glutamic oxaloacetic transaminase (SGOT) |
0.25[4] | 0.60[4] | µkat/L | |||
Male | 8[50] | 40[50] | IU/L | ||
0.25[4] | 0.75[4] | µkat/L | |||
Alkaline phosphatase (ALP) | 0.6[4] | 1.8[4] | µkat/L | ||
Female | 42[49] | 98[49] | U/L | ||
Male | 53[49] | 128[49] | |||
Gamma glutamyl transferase (GGT) | 5,[49] 8[10] | 40,[49] 78[10] | U/L | ||
Female | 0.63[51] | µkat/L | |||
Male | 0.92[51] | µkat/L |
Cardiac tests
Test | Patient type | Lower limit | Upper limit | Unit | Comments |
---|---|---|---|---|---|
Creatine kinase (CK) | Male | 24,[52] 38,[10] 60[49] | 174,[18] 320[49] | U/L or ng/mL | |
0.42[53] | 1.5[53] | µkat/L | |||
Female | 24,[52] 38,[10] 96[18] | 140,[18] 200[49] | U/L or ng/mL | ||
0.17[53] | 1.17[53] | µkat/L | |||
CK-MB | 0 | 3,[10] 3.8,[4] 5[49] | ng/mL or μg/L[4] | ||
Myoglobin | Female | 1[54] | 66[54] | ng/mL or µg/L | |
Male | 17[54] | 106[54] | |||
Cardiac troponin T | 0.01[55] | ng/mL | 99th percentile cutoff |
Brain natriuretic peptide (BNP)
-more detailed ranges in BNP article |
|
Interpretation | Range / Cutoff |
---|---|
Congestive heart failure unlikely | < 100 pg/mL[56][57] |
"Gray zone" | 100-500 pg/mL[56][57] |
Congestive heart failure likely | >500 pg/mL[56][57] |
NT-proBNP
-more detailed ranges in NT-proBNP article |
||
Interpretation | Age | Cutoff |
---|---|---|
Congestive heart failure likely | < 75 years | > 125 pg/mL[58] |
>75 years | >450pg/mL[58] |
Lipids
Blood lipids
Test | Patient type | Lower limit | Upper limit | Unit | Therapeutic target |
---|---|---|---|---|---|
Triglycerides | 10–39 years | 54[18] | 110[18] | mg/dL | < 100 mg/dL[59] or 1.1[59] mmol/L |
0.61[60] | 1.2[60] | mmol/L | |||
40–59 years | 70[18] | 150[18] | mg/dL | ||
0.77[60] | 1.7[60] | mmol/L | |||
> 60 years | 80[18] | 150[18] | mg/dL | ||
0.9[60] | 1.7[60] | mmol/L | |||
Total cholesterol | 3.0,[61] 3.6[9][61] | 5.0,[4][62] 6.5[9] | mmol/L | < 3.9 mmol/L[59] | |
120,[10] 140[9] | 200,[10] 250[9] | mg/dL | < 150 mg/dL[59] | ||
HDL cholesterol | Female | 1.0,[63] 1.2,[4] 1.3[61] | 2.2[63] | mmol/L | > 1.0[63] or
1.6[61] mmol/L 40[64] or 60[65] mg/dL |
40,[64] 50[66] | 86[64] | mg/dL | |||
HDL cholesterol | Male | 0.9[4][63] | 2.0[63] | mmol/L | |
35[64] | 80[64] | mg/dL | |||
LDL cholesterol (Not valid when triglycerides >5.0 mmol/L) |
2.0,[63] 2.4[62] | 3.0,[4][62] 3.4[63] | mmol/L | < 2.5 mmol/L[63] | |
80,[64] 94[64] | 120,[64] 130[64] | mg/dL | < 100 mg/dL[64] | ||
LDL/HDL quotient | n/a |
5[4] |